• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,113
103
69
68
65

COUNTRY

63
19
16
10
9

CATEGORIES

  • 88
  • 127
  • 68
  • 74
  • 43
  • 42
  • 20
  • 17
  • 18
  • 22

PRICE

563
809
1,568
2,551

PUBLISHED

78
137
710
2,551

PRODUCT TYPE

2,406
70
61
12
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Burkitt Lymphoma - Pipeline Review, H1 2013 Burkitt Lymphoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Burkitt Lymphoma - Pipeline Review, H1 2013

Burkitt Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Burkitt Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM
Indolent Lymphoma - Pipeline Review, H1 2013 Indolent Lymphoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Indolent Lymphoma - Pipeline Review, H1 2013

Indolent Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Indolent Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM
Osteosarcoma - Pipeline Review, H1 2013 Osteosarcoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Osteosarcoma - Pipeline Review, H1 2013

Osteosarcoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Osteosarcoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM

EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022

EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022 Chronic Myeloid Leukemia (CML) is a rare cancer of the white blood cells characterized by increased and unregulated growth of...

April 2013
FROM
Sarcomas - Pipeline Review, H1 2013 Sarcomas - Pipeline Review, H1 2013 - Product Thumbnail Image

Sarcomas - Pipeline Review, H1 2013

Sarcomas – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Sarcomas - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

April 2013
FROM
Global Lung Cancer Pipeline Capsule - 2013 Global Lung Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Lung Cancer Pipeline Capsule - 2013

Fore Pharma's latest report ‘Global Lung Cancer Pipeline Capsule – 2013' provides up-to-date information on key Research and Development (R&D) activities in the global lung cancer market It covers active...

April 2013
FROM
Global Gastric cancer Pipeline Capsule - 2013 Global Gastric cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Gastric cancer Pipeline Capsule - 2013

Fore Pharma’s latest report ‘Global Gastric cancer Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global gastric cancer market. It covers...

April 2013
FROM
Global Cervical Cancer Pipeline Capsule - 2013 Global Cervical Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Cervical Cancer Pipeline Capsule - 2013

Fore Pharma’s latest report ‘Global Cervical Cancer Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global cervical cancer market. It...

April 2013
FROM
Ovarian Cancer - Pipeline Review, H1 2013 Ovarian Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2013

Ovarian Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ovarian Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Glioma - Pipeline Review, H1 2013 Glioma - Pipeline Review, H1 2013 - Product Thumbnail Image

Glioma - Pipeline Review, H1 2013

Glioma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Glioma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

April 2013
FROM
Global Colorectal Cancer Pipeline Capsule - 2013 Global Colorectal Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Colorectal Cancer Pipeline Capsule - 2013

Fore Pharma’s latest report ‘Global Colorectal Cancer Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global colorectal cancer market....

April 2013
FROM
Global Breast Cancer Pipeline Capsule - 2013 Global Breast Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Breast Cancer Pipeline Capsule - 2013

Fore Pharma’s latest report ‘Global Breast Cancer Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global breast cancer market. It covers...

April 2013
FROM
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2013 Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2013 - Product Thumbnail Image

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2013

Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2013', provides an overview of the indication’s...

April 2013
FROM
Lung Cancer - Pipeline Review, H1 2013 Lung Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Lung Cancer - Pipeline Review, H1 2013

Lung Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Lung Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
T-Cell Lymphomas - Pipeline Review, H1 2013 T-Cell Lymphomas - Pipeline Review, H1 2013 - Product Thumbnail Image

T-Cell Lymphomas - Pipeline Review, H1 2013

T-Cell Lymphomas – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'T-Cell Lymphomas - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2013 Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2013 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2013

Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2013', provides an overview of the indication’s...

April 2013
FROM
Breast Cancer - Pipeline Review, H1 2013 Breast Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Breast Cancer - Pipeline Review, H1 2013

Breast Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Breast Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Global Bladder Cancer Pipeline Capsule - 2013 Global Bladder Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Bladder Cancer Pipeline Capsule - 2013

Fore Pharma’s latest report ‘Global Bladder Cancer Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global bladder cancer market. It covers...

April 2013
FROM
Squamous Cell Carcinoma - Pipeline Review, H1 2013 Squamous Cell Carcinoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Squamous Cell Carcinoma - Pipeline Review, H1 2013

Squamous Cell Carcinoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Squamous Cell Carcinoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Global Prostate Cancer Pipeline Capsule - 2013 Global Prostate Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Prostate Cancer Pipeline Capsule - 2013

Fore Pharma's latest report ‘Global Prostate Cancer Pipeline Capsule – 2013' provides up-to-date information on key Research and Development (R&D) activities in the global prostate cancer market It...

April 2013
FROM
Loading Indicator

Our Clients

Our clients' logos